PTC Therapeutics (PTCT) – Hot FDA News
-
PTC Therapeutics' (PTCT) Translarna Receives Negative CHMP Opinion
-
PTC Therapeutics (PTCT) Plunges 19% After Study in Friedreich Ataxia Misses Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PTCT Stock Lookup